Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tanzania | 40 | 2023 | 1346 | 1.480 |
Why?
|
| Nutritional Status | 7 | 2018 | 1609 | 0.780 |
Why?
|
| Zinc | 4 | 2023 | 683 | 0.770 |
Why?
|
| HIV Infections | 24 | 2023 | 16718 | 0.750 |
Why?
|
| Gastroesophageal Reflux | 6 | 2022 | 782 | 0.670 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2018 | 1873 | 0.670 |
Why?
|
| Vitamins | 6 | 2022 | 1621 | 0.670 |
Why?
|
| Anti-HIV Agents | 10 | 2016 | 4256 | 0.550 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2016 | 1320 | 0.540 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2018 | 303 | 0.540 |
Why?
|
| Infant Nutritional Physiological Phenomena | 5 | 2019 | 347 | 0.530 |
Why?
|
| Child Development | 5 | 2023 | 2223 | 0.520 |
Why?
|
| Dietary Supplements | 6 | 2023 | 3297 | 0.510 |
Why?
|
| Growth Disorders | 6 | 2022 | 645 | 0.480 |
Why?
|
| Biliary Tract Neoplasms | 4 | 2011 | 178 | 0.430 |
Why?
|
| Vitamin D | 3 | 2011 | 3222 | 0.420 |
Why?
|
| Diet | 7 | 2018 | 7937 | 0.390 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2015 | 387 | 0.390 |
Why?
|
| Pregnancy Outcome | 6 | 2022 | 2796 | 0.370 |
Why?
|
| Premature Birth | 5 | 2022 | 1721 | 0.370 |
Why?
|
| Anemia | 3 | 2023 | 1504 | 0.360 |
Why?
|
| Dyslipidemias | 3 | 2013 | 849 | 0.330 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2016 | 2026 | 0.310 |
Why?
|
| Gastroparesis | 2 | 2022 | 131 | 0.310 |
Why?
|
| Pregnancy | 22 | 2023 | 29142 | 0.310 |
Why?
|
| Diarrhea | 4 | 2020 | 1347 | 0.300 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 1912 | 0.280 |
Why?
|
| Flagellin | 2 | 2018 | 125 | 0.280 |
Why?
|
| Infant | 27 | 2023 | 35129 | 0.270 |
Why?
|
| Immunoglobulin A | 3 | 2023 | 992 | 0.270 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2019 | 378 | 0.260 |
Why?
|
| Insulin Resistance | 2 | 2009 | 3863 | 0.250 |
Why?
|
| Infant, Low Birth Weight | 2 | 2022 | 850 | 0.250 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2018 | 2559 | 0.250 |
Why?
|
| Blood Glucose | 5 | 2022 | 6259 | 0.240 |
Why?
|
| Breast Feeding | 5 | 2020 | 1339 | 0.230 |
Why?
|
| Female | 64 | 2023 | 380197 | 0.230 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 531 | 0.230 |
Why?
|
| Body Mass Index | 7 | 2022 | 12718 | 0.230 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2019 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2015 | 1912 | 0.210 |
Why?
|
| Glucose Tolerance Test | 3 | 2010 | 1150 | 0.210 |
Why?
|
| Turner Syndrome | 1 | 2023 | 130 | 0.200 |
Why?
|
| Puberty, Delayed | 1 | 2022 | 115 | 0.200 |
Why?
|
| Diet Records | 3 | 2018 | 425 | 0.200 |
Why?
|
| Lipids | 1 | 2013 | 3305 | 0.200 |
Why?
|
| Bronchiectasis | 1 | 2022 | 128 | 0.200 |
Why?
|
| Humans | 81 | 2023 | 744220 | 0.200 |
Why?
|
| Laryngomalacia | 1 | 2021 | 30 | 0.200 |
Why?
|
| Esophagitis, Peptic | 1 | 2021 | 78 | 0.190 |
Why?
|
| Lung Transplantation | 2 | 2021 | 1155 | 0.190 |
Why?
|
| Antidiarrheals | 1 | 2020 | 45 | 0.190 |
Why?
|
| Anti-Ulcer Agents | 1 | 2021 | 119 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2022 | 191 | 0.190 |
Why?
|
| Pregnant Women | 2 | 2022 | 568 | 0.180 |
Why?
|
| Risk Factors | 26 | 2022 | 72280 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2023 | 2279 | 0.180 |
Why?
|
| Infant, Newborn | 14 | 2022 | 25618 | 0.180 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2021 | 111 | 0.180 |
Why?
|
| Pregnancy Complications | 3 | 2022 | 2862 | 0.180 |
Why?
|
| Infant Mortality | 2 | 2016 | 754 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 382 | 0.180 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 386 | 0.170 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 2216 | 0.170 |
Why?
|
| Micronutrients | 1 | 2022 | 375 | 0.170 |
Why?
|
| Gastric Emptying | 2 | 2022 | 233 | 0.170 |
Why?
|
| Adult | 35 | 2022 | 214035 | 0.170 |
Why?
|
| Child | 21 | 2023 | 77679 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 1169 | 0.160 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 365 | 0.160 |
Why?
|
| Male | 48 | 2022 | 350027 | 0.160 |
Why?
|
| Stillbirth | 2 | 2022 | 346 | 0.160 |
Why?
|
| Mesalamine | 2 | 2023 | 136 | 0.160 |
Why?
|
| Hemoglobins | 3 | 2014 | 1533 | 0.160 |
Why?
|
| Crohn Disease | 2 | 2022 | 2303 | 0.160 |
Why?
|
| Respiratory System | 1 | 2021 | 557 | 0.160 |
Why?
|
| Multivariate Analysis | 6 | 2018 | 12244 | 0.160 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2015 | 810 | 0.150 |
Why?
|
| Prospective Studies | 19 | 2022 | 53280 | 0.150 |
Why?
|
| Milk, Human | 3 | 2022 | 490 | 0.150 |
Why?
|
| Sex Factors | 7 | 2018 | 10396 | 0.150 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.150 |
Why?
|
| Enteral Nutrition | 2 | 2022 | 763 | 0.150 |
Why?
|
| Microcephaly | 1 | 2022 | 432 | 0.150 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 378 | 0.150 |
Why?
|
| Iron | 2 | 2023 | 1774 | 0.150 |
Why?
|
| Child, Preschool | 13 | 2023 | 40992 | 0.150 |
Why?
|
| Overweight | 4 | 2018 | 2370 | 0.150 |
Why?
|
| Longitudinal Studies | 7 | 2022 | 13990 | 0.150 |
Why?
|
| Respiratory Tract Infections | 2 | 2017 | 961 | 0.140 |
Why?
|
| Intestine, Small | 2 | 2022 | 1241 | 0.140 |
Why?
|
| Thinness | 2 | 2018 | 479 | 0.140 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 104 | 0.140 |
Why?
|
| Diarrhea, Infantile | 2 | 2020 | 109 | 0.140 |
Why?
|
| Cholesterol | 3 | 2017 | 2911 | 0.140 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 93 | 0.140 |
Why?
|
| Folic Acid | 1 | 2022 | 1300 | 0.140 |
Why?
|
| Thyroidectomy | 1 | 2021 | 879 | 0.140 |
Why?
|
| Iron, Dietary | 1 | 2016 | 141 | 0.130 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 271 | 0.130 |
Why?
|
| Infant Nutrition Disorders | 2 | 2018 | 73 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 2425 | 0.130 |
Why?
|
| Inflammation | 5 | 2022 | 10634 | 0.130 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 605 | 0.130 |
Why?
|
| Gallstones | 3 | 2011 | 286 | 0.130 |
Why?
|
| Gestational Age | 3 | 2021 | 3493 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2010 | 5102 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2017 | 8551 | 0.130 |
Why?
|
| Cooking | 1 | 2017 | 313 | 0.130 |
Why?
|
| Body Height | 2 | 2018 | 1576 | 0.120 |
Why?
|
| Lamivudine | 1 | 2016 | 342 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2018 | 2408 | 0.120 |
Why?
|
| Prevalence | 7 | 2021 | 15226 | 0.120 |
Why?
|
| Weight Gain | 3 | 2022 | 2292 | 0.120 |
Why?
|
| Tea | 2 | 2006 | 275 | 0.120 |
Why?
|
| Dietary Proteins | 1 | 2019 | 963 | 0.120 |
Why?
|
| Adolescent | 15 | 2023 | 85759 | 0.120 |
Why?
|
| Diet Surveys | 1 | 2018 | 1173 | 0.120 |
Why?
|
| Calcium, Dietary | 1 | 2016 | 526 | 0.120 |
Why?
|
| Double-Blind Method | 6 | 2020 | 12035 | 0.120 |
Why?
|
| Triglycerides | 3 | 2011 | 2453 | 0.110 |
Why?
|
| Models, Biological | 1 | 2010 | 9582 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2023 | 9960 | 0.110 |
Why?
|
| Leptin | 1 | 2021 | 1599 | 0.110 |
Why?
|
| China | 7 | 2011 | 2247 | 0.110 |
Why?
|
| Aspirin | 1 | 2005 | 3282 | 0.110 |
Why?
|
| Developing Countries | 2 | 2022 | 2814 | 0.110 |
Why?
|
| Self Care | 1 | 2018 | 786 | 0.110 |
Why?
|
| Energy Intake | 2 | 2018 | 2148 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 3923 | 0.110 |
Why?
|
| Middle Aged | 21 | 2018 | 213367 | 0.110 |
Why?
|
| Anthropometry | 1 | 2017 | 1350 | 0.110 |
Why?
|
| Obesity | 6 | 2018 | 12742 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 511 | 0.100 |
Why?
|
| Gallbladder Neoplasms | 2 | 2011 | 183 | 0.100 |
Why?
|
| Testosterone | 1 | 2022 | 2411 | 0.100 |
Why?
|
| Proportional Hazards Models | 7 | 2018 | 12355 | 0.100 |
Why?
|
| Benchmarking | 1 | 2018 | 1042 | 0.100 |
Why?
|
| Young Adult | 12 | 2022 | 56436 | 0.100 |
Why?
|
| Urban Health | 3 | 2009 | 547 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 820 | 0.100 |
Why?
|
| Age Factors | 5 | 2021 | 18367 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2018 | 1092 | 0.090 |
Why?
|
| Cohort Studies | 11 | 2022 | 40559 | 0.090 |
Why?
|
| Celiac Disease | 1 | 2018 | 785 | 0.090 |
Why?
|
| Cross-Sectional Studies | 8 | 2018 | 25043 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2022 | 4151 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2016 | 2619 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1789 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1889 | 0.090 |
Why?
|
| Hospitalization | 4 | 2022 | 10262 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15538 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4559 | 0.080 |
Why?
|
| Placebos | 1 | 2013 | 1677 | 0.080 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 39045 | 0.080 |
Why?
|
| Vomiting | 2 | 2022 | 635 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 2281 | 0.080 |
Why?
|
| Health Status | 2 | 2011 | 4034 | 0.080 |
Why?
|
| Hypertension | 3 | 2017 | 8480 | 0.080 |
Why?
|
| Treatment Outcome | 10 | 2022 | 63119 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 3336 | 0.080 |
Why?
|
| Placenta | 1 | 2016 | 1697 | 0.080 |
Why?
|
| Retrospective Studies | 12 | 2022 | 77426 | 0.070 |
Why?
|
| Dietary Sucrose | 1 | 2009 | 247 | 0.070 |
Why?
|
| Environment | 3 | 2018 | 1124 | 0.070 |
Why?
|
| Anti-Retroviral Agents | 2 | 2014 | 1715 | 0.070 |
Why?
|
| HIV-1 | 2 | 2016 | 6938 | 0.070 |
Why?
|
| Algorithms | 3 | 2021 | 13885 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 11732 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1904 | 0.070 |
Why?
|
| Meat | 1 | 2009 | 595 | 0.070 |
Why?
|
| Fasting | 1 | 2011 | 1591 | 0.060 |
Why?
|
| Research Design | 1 | 2021 | 5987 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1372 | 0.060 |
Why?
|
| Protective Agents | 1 | 2005 | 156 | 0.060 |
Why?
|
| Cause of Death | 2 | 2005 | 3584 | 0.060 |
Why?
|
| Insulin | 2 | 2009 | 6583 | 0.060 |
Why?
|
| Pediatrics | 1 | 2019 | 3469 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6367 | 0.060 |
Why?
|
| Logistic Models | 5 | 2021 | 13409 | 0.060 |
Why?
|
| Birth Weight | 2 | 2022 | 2069 | 0.060 |
Why?
|
| Fruit | 1 | 2009 | 1142 | 0.060 |
Why?
|
| Vegetables | 1 | 2009 | 1182 | 0.060 |
Why?
|
| Clarithromycin | 1 | 2023 | 86 | 0.050 |
Why?
|
| Sulfasalazine | 1 | 2022 | 79 | 0.050 |
Why?
|
| Chemoprevention | 1 | 2005 | 319 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 20945 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 2014 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4236 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2009 | 1814 | 0.050 |
Why?
|
| Body Constitution | 1 | 2022 | 278 | 0.050 |
Why?
|
| Body Composition | 1 | 2011 | 2400 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7281 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2715 | 0.050 |
Why?
|
| Malnutrition | 2 | 2018 | 625 | 0.050 |
Why?
|
| Azathioprine | 1 | 2022 | 355 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2022 | 124 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2019 | 21752 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2009 | 2017 | 0.050 |
Why?
|
| Bile | 1 | 2021 | 296 | 0.050 |
Why?
|
| Karyotyping | 1 | 2023 | 1243 | 0.050 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2022 | 300 | 0.050 |
Why?
|
| Intestines | 2 | 2022 | 1924 | 0.050 |
Why?
|
| Middle East | 1 | 2020 | 219 | 0.050 |
Why?
|
| Ferritins | 1 | 2023 | 590 | 0.050 |
Why?
|
| Menarche | 1 | 2023 | 516 | 0.040 |
Why?
|
| New England | 1 | 2023 | 1022 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2022 | 703 | 0.040 |
Why?
|
| Glottis | 1 | 2021 | 217 | 0.040 |
Why?
|
| Linear Models | 3 | 2018 | 5953 | 0.040 |
Why?
|
| Nausea | 1 | 2022 | 668 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3188 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2022 | 881 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 571 | 0.040 |
Why?
|
| Orosomucoid | 1 | 2018 | 45 | 0.040 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3778 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 732 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 16365 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2005 | 2539 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 12805 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2018 | 379 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2020 | 724 | 0.040 |
Why?
|
| Pakistan | 1 | 2018 | 296 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2018 | 128 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2019 | 309 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 1877 | 0.040 |
Why?
|
| Food Analysis | 1 | 2017 | 104 | 0.040 |
Why?
|
| Ileum | 1 | 2019 | 565 | 0.040 |
Why?
|
| Apgar Score | 1 | 2016 | 123 | 0.040 |
Why?
|
| Prescriptions | 1 | 2019 | 387 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 423 | 0.040 |
Why?
|
| Infant Food | 1 | 2016 | 141 | 0.030 |
Why?
|
| Boston | 2 | 2019 | 9311 | 0.030 |
Why?
|
| Esophageal pH Monitoring | 1 | 2017 | 191 | 0.030 |
Why?
|
| Age of Onset | 1 | 2022 | 3270 | 0.030 |
Why?
|
| Restaurants | 1 | 2018 | 236 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1036 | 0.030 |
Why?
|
| Aged | 10 | 2018 | 163253 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Risk | 2 | 2018 | 9685 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2021 | 1172 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1223 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7179 | 0.030 |
Why?
|
| HIV Wasting Syndrome | 1 | 2014 | 97 | 0.030 |
Why?
|
| Time Factors | 4 | 2022 | 40063 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2914 | 0.030 |
Why?
|
| Lung | 2 | 2022 | 9852 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2016 | 723 | 0.030 |
Why?
|
| Leukocytes | 1 | 2021 | 2040 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2015 | 440 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3300 | 0.030 |
Why?
|
| Travel | 1 | 2018 | 788 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 1402 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
| Employment | 1 | 2018 | 1129 | 0.020 |
Why?
|
| Methotrexate | 1 | 2018 | 1720 | 0.020 |
Why?
|
| Disease Progression | 2 | 2021 | 13280 | 0.020 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 3966 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2014 | 310 | 0.020 |
Why?
|
| Colon | 1 | 2019 | 1772 | 0.020 |
Why?
|
| Maternal Age | 1 | 2014 | 802 | 0.020 |
Why?
|
| Infant Welfare | 1 | 2011 | 82 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 7784 | 0.020 |
Why?
|
| Cholecystitis | 1 | 2011 | 182 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5755 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1766 | 0.020 |
Why?
|
| Ulcer | 1 | 2011 | 209 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3469 | 0.020 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2009 | 54 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3690 | 0.020 |
Why?
|
| United States | 3 | 2023 | 69867 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2062 | 0.020 |
Why?
|
| Mental Health | 1 | 2023 | 3019 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1176 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3036 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10949 | 0.020 |
Why?
|
| Marijuana Smoking | 1 | 2011 | 253 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 639 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6485 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2021 | 5982 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 3913 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2011 | 9849 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 8986 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2210 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3741 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 638 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2016 | 1859 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2019 | 3313 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15161 | 0.020 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2005 | 49 | 0.020 |
Why?
|
| Morbidity | 1 | 2011 | 1769 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2165 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 4666 | 0.020 |
Why?
|
| Neoplasms | 2 | 2004 | 21672 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 1320 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 2006 | 411 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2016 | 2494 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2014 | 6461 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12075 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3023 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 443 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12781 | 0.010 |
Why?
|
| Aging | 1 | 2021 | 8661 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2009 | 1167 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6535 | 0.010 |
Why?
|
| Phenols | 1 | 2005 | 501 | 0.010 |
Why?
|
| Exercise | 1 | 2016 | 5615 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19907 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5138 | 0.010 |
Why?
|
| Health Promotion | 1 | 2009 | 2205 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2009 | 23337 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2004 | 1333 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5252 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4252 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 168788 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 6773 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13096 | 0.000 |
Why?
|
Concepts
(321)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_